WST R&D to Revenue
West Pharmaceutical Services · R&D to Revenue

WST R&D to Revenue
Latest reported2.42%period ending
WST FY R&D/Revenue (0.00% → 2.42%)
Latest values, visible window
High-resolution chart · PNG
WST r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 2.4173% | |
| 2.3888% | |
| 2.3178% | |
| 2.0274% | |
| 1.8653% | |
| 2.1847% | |
| 2.11% | |
| 2.3458% | |
| 2.4434% | |
| 2.4385% | |
| 2.4392% | |
| 2.6236% | |
| 2.7701% | |
| 2.6216% | |
| 2.44% | |
| 2.1635% | |
| 1.885% | |
| 1.7791% | |
| 1.5783% | |
| 1.2154% | |
| 1.1291% | |
| 1.1632% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |